This study tests an experimental drug called TT125-802 in about 50 adults with advanced solid tumors (like lung cancer) that have stopped responding to standard treatments. The main goals are to check the drug's safety and find the right dose. Researchers will also watch for sign…
Phase: PHASE1 • Sponsor: TOLREMO therapeutics AG • Aim: Disease control
Last updated May 18, 2026 12:04 UTC